Medical News
Comparison of Electrocardiograms (ECG) Waveforms and Central...
Ann Noninvasive Electrocardiol.
The 6-lead hand-held device is potentially useful for a clinical follow-up of remote patients, and for a safety...
22 Jul 2021
Incidence and Predictors of Stent Thrombosis in Patients Tre...
Am J Cardiol.
In conclusion, age, smoking status, chronic kidney disease and a 2-stent strategy were significant predictors of ST...
21 Jul 2021
Risk Factors and Lifestyles in the Development of Atrial Fib...
Am J Cardiol.
In conclusion, high waist circumference, hypertension, cigarette smoking, and poor sleep quality were associated...
20 Jul 2021
Clinical History and Gastrointestinal Bleeding in Patients t...
Int J Cardiol.
The patients' clinical history is neither a predictor for GIB bleeding nor a guide to the choice of the oral...
19 Jul 2021
eCMEs
Key Trials
COMPASS: Rivaroxaban Plus Aspirin reduces the Death Risk vs. Aspirin alone in Patients with Chronic CAD and PAD
This sub-analysis of the COMPASS trial demonstrated that patients with chronic CAD or PAD treated with rivaroxaban-aspirin combination had a reduced...
The Prevalence of Atrial Fibrillation and its Treatment Vary Globally
The prevalence of AF varies widely across the global. Despite the high risk of stroke associated with AF, the use of antithrombotics is less common...
Prolonging DAPT beyond 1 Year may be Effective and Safe in the ESC/EACT Guideline-endorsed High Thrombotic Risk Patients undergoing PCI
According to the findings of the study, prolonging DAPT beyond 1 year in ESC/EACTS guideline-endorsed high thrombotic risk patients, reduced the...
SGLT-2i as Compared with other Antidiabetic Drugs, does not Increase the Risk of Lower Limb Amputation in T2DM Patients
This large-scale study demonstrates no increased risk of lower limb amputation with SGLT-2i other antidiabetic drugs in T2DM patients. T2DM patients...
Slide Library
Medical Management Strategy of CTEPH: Role of Riociguat
Riociguat, a stimulator of soluble guanylate cyclase, has been globally approved for the treatment of PAH and inoperable CTEPH and persistent/...
Macitentan: 1st ERA Proven to Reduce Morbidity and Mortality in PAH
Macitentan is an orally active, potent, tissue targeting ERA that is indicated for the treatment of pulmonary arterial hypertension (PAH). It is the...
Chronic Thromboembolic Pulmonary Hypertension
Chronic thromboembolic pulmonary hypertension (CTEPH) is the presence of mean pulmonary artery pressure (mPAP) ≥ 25 mmHg following an episode of...
Diabetic Dyslipidemia
Dyslipidemia is one of the key risk factors for cardiovascular disease (CVD) in diabetes mellitus. This slide set provides information on the...
Our Publications
Rivazest (Rivaroxaban) Monograph
Rivaroxaban is a potent, selective, orally active direct inhibitor of the activated serine protease Factor X (FXa), which plays a central role in...
Telyse (Tenecteplase) Monograph
In the management of STEMI in India, pharmacoinvasive strategy involving thrombolytics is the preferred therapy in cases of delays in primary PCI....
Mexiletine FAQ Booklet
Mexiletine is a class 1B antiarrhythmic agent, which blocks the sodium channels and is indicated in suppression of ventricular arrhythmias. The...
Mexohar (Mexiletine) Monograph
About 5% of patients with cardiac arrhythmias or with heart failure are diagnosed with a ventricular tachycardia. Recurrent Ventricular Tachycardia...
Patient Education
Understanding Angioplasty
Angioplasty is a life-saving procedure to open up blocked or narrowed blood vessels. This document gives a brief idea about the procedure.
Understanding Obesity
This document explains what is obesity, what is the impact of obesity on overall health and what are the benefits of weight loss.
Hypertension
Know more about the risk factors, associated ill-effects and tips for management of hypertension or high blood pressure.
Poll
What percent of your patients who need oral anticoagulation, receive warfarin?
<20%
20-40%
40-50%
50-70%
70-80%
Almost all
Total votes: 28